1st Quarter - Report

POLICY DIRECTIONS INC. for CELLERANT THERAPEUTICS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Increased funding for Biodefense advanced research development through BARDA.

LobbyistCovered position, as disclosed
STEPHEN MICHAEL —
FRANKIE L TRULL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.